Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
FLXN
|
Christina Willwerth
Chief Strategy Officer |
SELL
Open market or private sale
|
Direct | 6,602 Reduced 5.42% |
$73,480
$11.13 p/Share
|
Jan 05
2021 |
|
FLXN
|
Mark S. Levine
General Counsel |
SELL
Open market or private sale
|
Direct | 6,829 Reduced 5.98% |
$76,007
$11.13 p/Share
|
Jan 05
2021 |
|
FLXN
|
David Arkowitz
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 6,073 Reduced 3.87% |
$67,592
$11.13 p/Share
|
Jan 05
2021 |
|
BLFS
|
Walter Villiger
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 18,948 Reduced 0.51% |
$806,048
$42.54 p/Share
|
Jan 05
2021 |
|
BLUE
|
Nick Leschly |
SELL
Open market or private sale
|
Direct | 333 Reduced 0.34% |
$14,968
$44.95 p/Share
|
Jan 05
2021 |
|
BLUE
|
Alison Cecily Finger
Chief Commercial Officer |
SELL
Open market or private sale
|
Direct | 40 Reduced 0.15% |
$1,798
$44.95 p/Share
|
Jan 05
2021 |
|
BLUE
|
David Davidson
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 48 Reduced 0.12% |
$2,158
$44.95 p/Share
|
Jan 05
2021 |
|
BLUE
|
Jason Cole
Chief Strategy & Financial Off |
SELL
Open market or private sale
|
Direct | 43 Reduced 0.12% |
$1,933
$44.95 p/Share
|
Jan 05
2021 |
|
BLUE
|
Joanne Smith Farrell
COO, Oncology |
SELL
Open market or private sale
|
Direct | 42 Reduced 0.19% |
$1,888
$44.95 p/Share
|
Jan 05
2021 |
|
BLUE
|
Philip D Gregory
Chief Scientific Officer |
SELL
Open market or private sale
|
Direct | 45 Reduced 0.13% |
$2,023
$44.95 p/Share
|
Jan 05
2021 |
|
BUDZ
|
Nicole M Breen
Secretary/Treasurer |
SELL
Open market or private sale
|
Indirect | 19,000 Reduced 0.04% |
$4,370
$0.23 p/Share
|
Jan 05
2021 |
|
ATAO
|
Erop Capital LLC |
SELL
Open market or private sale
|
Direct | 117,000 Reduced 0.24% |
$30,420
$0.26 p/Share
|
Jan 05
2021 |
|
HHC
|
James Carman
President, Houston Region |
SELL
Open market or private sale
|
Direct | 192 Reduced 7.7% |
$15,012
$78.19 p/Share
|
Jan 05
2021 |
|
IDRA
|
Bryant David Lim
SVP AND GENERAL COUNSEL |
SELL
Open market or private sale
|
Direct | 1,465 Reduced 3.55% |
$5,728
$3.91 p/Share
|
Jan 05
2021 |
|
IDRA
|
Vincent Milano |
SELL
Open market or private sale
|
Direct | 2,740 Reduced 1.28% |
$10,713
$3.91 p/Share
|
Jan 05
2021 |
|
OGEN
|
Joseph Hernandez
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 500,000 Reduced 12.43% |
$290,000
$0.58 p/Share
|
Jan 05
2021 |
|
ICCH
|
Rock Island Investors, LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 1,097 Reduced 0.28% |
$15,676
$14.29 p/Share
|
Jan 05
2021 |
|
MERC
|
Eric Xavier Heine
Vice President |
SELL
Open market or private sale
|
Direct | 195 Reduced 0.3% |
$2,028
$10.4 p/Share
|
Jan 05
2021 |
|
CVEO
|
Lance Torgerson
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 400 Reduced 0.02% |
$7,808
$19.52 p/Share
|
Jan 04
2021 |
|
BALY
|
Jeffrey W Rollins
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 6.44% |
$241,450
$48.29 p/Share
|
Jan 04
2021 |
|
ANSS
|
Richard S. Mahoney
SVP, WORLDWIDE SALES & SUPPORT |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 16.39% |
$2,733,975
$364.53 p/Share
|
Jan 04
2021 |
|
RUN
|
Edward Harris Fenster
Director |
SELL
Open market or private sale
|
Direct | 54,092 Reduced 3.27% |
$3,831,877
$70.84 p/Share
|
Jan 04
2021 |
|
CORT
|
Joseph Douglas Lyon |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 100.0% |
$653,250
$26.13 p/Share
|
Jan 04
2021 |
|
GNK
|
Ccp Ii Cayman Gp Ltd.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 40,000 Reduced 0.78% |
$303,600
$7.59 p/Share
|
Jan 04
2021 |
|
GNK
|
Centerbridge Credit Partners, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 40,000 Reduced 0.78% |
$303,600
$7.59 p/Share
|
Jan 04
2021 |
|
INTU
|
Michelle M Clatterbuck
EVP and CFO |
SELL
Open market or private sale
|
Direct | 412 Reduced 43.01% |
$156,243
$379.23 p/Share
|
Jan 04
2021 |
|
INTU
|
James Alexander Chriss
Executive Vice President |
SELL
Open market or private sale
|
Direct | 298 Reduced 57.42% |
$113,011
$379.23 p/Share
|
Jan 04
2021 |
|
LEVI
|
Seth Jaffe
EVP & Chief Legal Officer |
SELL
Open market or private sale
|
Direct | 10,631 Reduced 11.32% |
$209,324
$19.69 p/Share
|
Jan 04
2021 |
|
EW
|
Jean Luc M Lemercier
CVP, EMEACLA and JAPAC |
SELL
Open market or private sale
|
Direct | 20,523 Reduced 12.85% |
$1,872,518
$91.24 p/Share
|
Jan 04
2021 |
|
ZS
|
Karen Blasing
Director |
SELL
Open market or private sale
|
Direct | 3,000 Reduced 83.45% |
$589,980
$196.66 p/Share
|
Jan 04
2021 |
|
HALO
|
Kenneth J Kelley
Director |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 2.5% |
$215,650
$43.13 p/Share
|
Jan 04
2021 |
|
BWXT
|
Richard W Loving
SVP and CAO |
SELL
Open market or private sale
|
Direct | 300 Reduced 2.29% |
$18,084
$60.28 p/Share
|
Jan 04
2021 |
|
SAM
|
John C Geist
Chief Sales Officer |
SELL
Open market or private sale
|
Direct | 262 Reduced 5.39% |
$259,679
$991.14 p/Share
|
Jan 04
2021 |
|
SEAS
|
Walter Bogumil
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 16,000 Reduced 7.07% |
$503,840
$31.49 p/Share
|
Jan 04
2021 |
|
CYTK
|
Robert I Blum
President & CEO |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 1.61% |
$101,150
$20.23 p/Share
|
Jan 04
2021 |
|
NUS
|
D Matthew Dorny
General Counsel |
SELL
Open market or private sale
|
Direct | 6,200 Reduced 12.26% |
$342,364
$55.22 p/Share
|
Jan 04
2021 |
|
AMK
|
Ted F. Angus
EVP, General Counsel |
SELL
Open market or private sale
|
Direct | 13,847 Reduced 8.24% |
$334,128
$24.13 p/Share
|
Jan 04
2021 |
|
EVOP
|
Darren Wilson
President, International |
SELL
Open market or private sale
|
Direct | 4,000 Reduced 5.18% |
$108,000
$27.0 p/Share
|
Jan 04
2021 |
|
MLAB
|
John James Sullivan
Director |
SELL
Open market or private sale
|
Direct | 1,250 Reduced 2.03% |
$351,025
$280.82 p/Share
|
Jan 04
2021 |
|
RAPT
|
William Ho
CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 1.44% |
$19,750
$19.75 p/Share
|
Jan 04
2021 |
|
VLGEA
|
John Sumas
EVP & Secretary |
SELL
Open market or private sale
|
Direct | 596 Reduced 0.52% |
$12,951
$21.73 p/Share
|
Jan 04
2021 |
|
OMCL
|
Robin Gene Seim |
SELL
Open market or private sale
|
Direct | 1,319 Reduced 3.58% |
$157,779
$119.62 p/Share
|
Jan 04
2021 |
|
ACBI
|
Robert R Bugbee Ii
CHIEF CREDIT OFFICER |
SELL
Open market or private sale
|
Direct | 1,000 Reduced 2.63% |
$15,740
$15.74 p/Share
|
Jan 04
2021 |
|
ADP
|
Douglas W Politi
Corp. VP |
SELL
Open market or private sale
|
Direct | 6,747 Reduced 25.32% |
$1,187,270
$175.97 p/Share
|
Jan 04
2021 |
|
IBKR
|
Thomas Aj Frank
Executive Vice President |
SELL
Open market or private sale
|
Direct | 18,337 Reduced 1.24% |
$1,115,623
$60.84 p/Share
|
Jan 04
2021 |
|
IBKR
|
Paul Jonathan Brody
Chief Financial Officer |
SELL
Open market or private sale
|
Indirect | 2,558 Reduced 0.81% |
$155,629
$60.84 p/Share
|
Jan 04
2021 |
|
TWLO
|
George Hu
Strategic Advisor |
SELL
Open market or private sale
|
Direct | 5,000 Reduced 4.14% |
$1,679,200
$335.84 p/Share
|
Jan 04
2021 |
|
FOLD
|
John F Crowley
Executive Chairman |
SELL
Open market or private sale
|
Direct | 7,500 Reduced 1.0% |
$166,275
$22.17 p/Share
|
Jan 04
2021 |
|
FOLD
|
Bradley L Campbell
President and CEO |
SELL
Open market or private sale
|
Direct | 10,514 Reduced 3.32% |
$233,095
$22.17 p/Share
|
Jan 04
2021 |
|
DIOD
|
Shew Lu Keh |
SELL
Open market or private sale
|
Indirect | 14,094 Reduced 2.44% |
$1,011,385
$71.76 p/Share
|
Jan 04
2021 |